Popular Antidepressant Recalled Over Possible Cancer-Causing Impurity Risk

  • تاريخ النشر: منذ ساعة زمن القراءة: دقيقة قراءة

Key recall details, affected lot codes, and why patients should verify bottles before making any medication changes.

Duloxetine Is the Drug Involved

Breckenridge Pharmaceutical Issued the Recall

The Concern Is Nitrosamine Contamination

The 30 mg Bottles Have One Listed Lot

The 60 mg Recall Is Much Larger

Several 60 mg Lot Codes Are Named

Class II Does Not Mean the Highest Alert

Nitrosamines Are Not Unique to This Drug

Patients Should Not Stop Suddenly

The Practical Step Is Bottle Verification

  • 1 / 10
مقالات ذات صلة
Pesticide Risks In 9 Popular Fruits And How To Wash Them Right
‘Do Not Eat’ Warning as Dairy-Free Chocolate Bar Recalled Over Hidden Risk
6 Possible Side Effects of Black Seed Oil

A major recall involving duloxetine has raised concern because the medicine is widely used and often taken as part of a carefully managed mental health or pain-treatment plan. The issue is not about a wrong label or a packaging mistake, but an impurity tied to a possible long-term cancer risk.

Breckenridge Pharmaceutical, Inc. recalled nearly 375,000 bottles on June 4, 2026, after higher-than-acceptable levels of nitrosamines were identified. The FDA classified the recall as Class II on June 8, meaning the affected drugs may cause temporary or medically reversible health consequences, while the probability of serious consequences is remote.

مواضيع ذات صلة